Market Research Reports - Ken Research Global Glaucoma-Epidemiology Market Forecast
Global Glaucoma-Epidemiology Market Forecast to 2026: Ken Research
Glaucoma is a common, asymptomatic group of eye diseases that causes damage to the
eye'soptic nerve, resulting in progressive, irreversible vision loss. Glaucoma is one of the leading
causes of blindness worldwide, especially in elderly people. Glaucoma is generally categorized
as open-angle glaucoma (OAG), angle-closure glaucoma (ACG), or secondary glaucoma (SG),
though other less common types exist. OAG and ACG can be classified as primary (primary
open-angle glaucoma [POAG] or primary angle-closure glaucoma [PACG], respectively) or SG,
depending on the cause.
To forecast the total prevalent cases of POAG, PACG, NTG, PPG, and SG in the 7MM, Global
Data epidemiologists selected nationally representative, population-based studies that
provided these epidemiological data in the 7MM. Global Data epidemiologists obtained data for
the diagnosed prevalent cases of PPG from primary market research and authentic secondary
sources. In addition, the forecast is supported by robust, country-specific data that were
obtained from various authentic sources, such as research articles published in peer-reviewed
journals.
In the 7MM, the total prevalent cases of POAG will increase from 7,224,135 cases in 2016 to
8,549,547 cases in 2026, at an Annual Growth Rate (AGR) of 1.83%. In the 7MM, the total
prevalent cases of PACG will increase from 2,644,012 cases in 2016 to 3,124,740 cases in 2026,
at an AGR of 1.82%. Global Data forecasts that all markets will see an increase in the total
prevalent cases and diagnosed prevalent cases of POAG and PACG during the forecast period.
The Glaucoma EpiCast Report provides an overview of the risk factors and global trends of
glaucoma in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year
epidemiological forecast for the total prevalent cases and diagnosed prevalent cases of primary
open-angle glaucoma (POAG) or primary angle-closure glaucoma (PACG), segmented by sex and
age (40-49 years, 50-59 years, 60-69 years, 70-79 years, and ages 80 years and older) in these
markets. In addition, this report provides a 10-year epidemiological forecast for the total
prevalent cases and diagnosed prevalent cases of glaucoma clinical types normal-tension
glaucoma (NTG), pre perimetric glaucoma (PPG), and secondary glaucoma (SG). The report also
includes the diagnosed incident cases of acute PACG. The glaucoma epidemiology report is
written and developed by Masters- and PhD-level epidemiologists. The EpiCast Report is in-
depth, high quality, transparent and market-driven, providing expert analysis of disease trends
in the 7MM.
Key Topics Covered in the Report:
Global Glaucoma-Epidemiology Market Forecast